By 2050, one in three Americans is expected to have diabetes and will be at increased risk for dementia. While diabetes is associated with reduced availability of central insulin, little is known about how this deficiency specifically alters neuronal function, particularly in the acute state. Insulin has been shown to affect neuronal signaling, akin to a classic neuromodulator, where it can act on inhibitory and/or excitatory neurotransmission. Yet fundamental questions remain about how the loss of insulin receptor signaling might affect intact neuronal networks in vivo, and thus the biophysical behavior of neuronal membranes and molecular signaling that is important for learning and memory. Murine primary sensory cortex provides a model that enables these questions to be addressed. It has clear and well-known physiological roles in both sensory coding and learning, and advanced tools are available to quantify the effects of experimental changes, such as insulin-mediated neuromodulation. Questions asked in this animal model can be further explored in both mutant and transgenic mouse lines that yield diabetic phenotypes. Here we propose to use molecular biology, patch-clamp recording, and multi-electrode arrays coupled to in vivo pharmacology to elucidate roles for insulin neuromodulation at central sensory neurons. Experiments will be carried out in wildtype, untreated, and insulin-treated mutant Akita mice (model of insulin deficient Type 1 diabetes). Scientifically, this proposal is organized to address three main aims. We will determine: 1) the functional organization of insulin-associated circuits, and demonstrate the extent to which these networks are engaged by auditory experience 2) how insulin, and its deficiency, affects synaptic transmission in A l , and 3) how insulin, or dysfunctional insulin signaling, modulates the physiology of Al neurons during auditory processing and discrimination in the awake brain. The work proposed in this application is an important first step to investigate a possible need for the lifelong regulation of central insulin in people with diabetes. Moreover, the data may also support the use of treatments such as intra-nasal insulin to combat diabetes related cognitive impairment and dementias.

Public Health Relevance

Diabetes doubles one's risk for Alzheimer's disease or other dementias. While dementia patients treated with centrally acting insulin experience improved cognitive function, potential benefits of central insulin treatment in diabetics are not known. In part, this is because the physiological impacts of central insulin and the effects of its loss in diabetes are poorly understood. To address this gap, this study examines neuromodulatory roles of central insulin in wildtype and mutant mice with type 1 diabetes.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Exploratory Grants (P20)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RI-B)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Oklahoma Health Sciences Center
Oklahoma City
United States
Zip Code
Wang, Bing; Li, Pui-Kai; Ma, Jian-Xing et al. (2018) Therapeutic Effects of a Novel Phenylphthalimide Analog for Corneal Neovascularization and Retinal Vascular Leakage. Invest Ophthalmol Vis Sci 59:3630-3642
Shin, Younghwa; Moiseyev, Gennadiy; Petrukhin, Konstantin et al. (2018) A novel RPE65 inhibitor CU239 suppresses visual cycle and prevents retinal degeneration. Biochim Biophys Acta Mol Basis Dis 1864:2420-2429
Fu, Shuhua; Dong, Shuqian; Zhu, Meili et al. (2018) VEGF as a Trophic Factor for Müller Glia in Hypoxic Retinal Diseases. Adv Exp Med Biol 1074:473-478
Orock, Albert; Logan, Sreemathi; Deak, Ferenc (2018) Munc18-1 haploinsufficiency impairs learning and memory by reduced synaptic vesicular release in a model of Ohtahara syndrome. Mol Cell Neurosci 88:33-42
Chen, Qian; Qiu, Fangfang; Zhou, Kelu et al. (2017) Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPAR?. Diabetes 66:1671-1682
Du, Mei; Martin, Ashley; Hays, Franklin et al. (2017) Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4. Mol Vis 23:185-197
Malechka, Volha V; Moiseyev, Gennadiy; Takahashi, Yusuke et al. (2017) Impaired Rhodopsin Generation in the Rat Model of Diabetic Retinopathy. Am J Pathol 187:2222-2231
Qiu, Fangfang; Liu, Zhen; Zhou, Yueping et al. (2017) Decreased Circulating Levels of Dickkopf-1 in Patients with Exudative Age-related Macular Degeneration. Sci Rep 7:1263
Pearsall, Elizabeth A; Cheng, Rui; Zhou, Kelu et al. (2017) PPAR? is essential for retinal lipid metabolism and neuronal survival. BMC Biol 15:113
Le, Yun-Zheng (2017) VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases. Vision Res 139:108-114

Showing the most recent 10 out of 101 publications